NOVEL ANTIANDROGEN ARN-509 IN HIGH-RISK NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Shore, Neal D.
Antonarakis, Emmanuel S.
Ryan, Charles J.
Berry, William R.
Liu, Glenn
Higano, Celestia
Maneval, Edna Chow
Bandekar, Rajesh
de Boer, Carla J.
Todd, Mary B.
Yu, Margaret K.
Rathkopf, Dana E.
Smith, Matthew R.
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.1961
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP87-16
引用
收藏
页码：E1090 / E1090
页数：1
相关论文
共 50 条
  • [31] ARAMIS trial: Efficacy and safety of ODM-201 in men with high-risk nonmetastatic castration-resistant prostate cancer
    Suzuki, Kazuhiro
    Kuss, Iris
    Smith, Matthew R.
    Fizazi, Karim
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease
    Henriquez, Ivan
    Spratt, Daniel
    Gomez-Iturriaga, Alfonso
    Abuchaibe, Oscar
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (01): : 6 - 12
  • [33] Novel Nonsteroidal Antiandrogens and Overall Survival in Nonmetastatic Castration-resistant Prostate Cancer
    Bhindi, Bimal
    Karnes, R. Jeffrey
    EUROPEAN UROLOGY, 2018, 74 (04) : 534 - 535
  • [34] Phase 1b study of ARN-509 with abiraterone acetate (AA) and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Posadas, Edwin M.
    Chi, Kim N.
    De Wit, Ronald
    De Jonge, Maja J.
    Attard, Gerhardt
    Friedlander, Terence W.
    Yu, Margaret K.
    Hellemans, Peter
    Chien, Caly
    Abrams, Charlene Connelly
    Gonzalez, Martha
    Trudel, Geralyn Carol
    Chauhan, Vijay
    Jiao, Juhui James
    Saad, Fred
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] Does nonmetastatic castration-resistant prostate cancer still exist?
    Higano, Celestia S.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (06) : 350 - 351
  • [36] Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
    Rhea, Logan P.
    Gupta, Brinda
    Aragon-Ching, Jeanny B.
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (02) : 107 - 108
  • [37] Does nonmetastatic castration-resistant prostate cancer still exist?
    Celestia S. Higano
    Nature Reviews Clinical Oncology, 2018, 15 : 350 - 351
  • [38] Salvage Radical Prostatectomy in Nonmetastatic Castration-Resistant Prostate Cancer
    Lopez-Fontana, Gaston
    Manuel Guglielmi, Juan
    Lopez-Fontana, Rodrigo
    Lis Hinojosa-Jury, Mariana
    Lopez-Fontana, Constanza
    Daniel Lopez-Laur, Jose
    ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (07): : 638 - 641
  • [39] Apalutamide Approved for Use in Nonmetastatic Castration-Resistant Prostate Cancer
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 273 - 273
  • [40] Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
    Arnaldo Figueiredo
    Luís Costa
    Maria Joaquina Maurício
    Luís Figueira
    Rodrigo Ramos
    Carlos Martins-da-Silva
    Clinical Drug Investigation, 2022, 42 : 631 - 642
12345